The Role of microRNA-29b in the Oral Squamous Cell Carcinoma (microRNA-29b)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02009852|
Recruitment Status : Unknown
Verified December 2013 by National Taiwan University Hospital.
Recruitment status was: Not yet recruiting
First Posted : December 12, 2013
Last Update Posted : December 12, 2013
|Condition or disease|
To find out if there is prognostic value which to the performance of microRNA-29b of oral cancer in Taiwan and provide some reference for future treatment.
We anticipate to enroll 100 persons with oral cancer and collect the tissue which was stained for pathological sections over a 3 year period.
We also collect the blood and saliva samples from patients and the results along with patient-specific information such as tumor phases, tumor size, lymph node metastasis, cancer metastasis, prognosis and betel nut chewing, smoking and drinking habits and other parameters are statistically analyzed.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||100 participants|
|Target Follow-Up Duration:||3 Years|
|Official Title:||The Role of microRNA-29b in the Oral Squamous Cell Carcinoma|
|Study Start Date :||January 2014|
|Estimated Primary Completion Date :||December 2014|
Subjects who suffer from oral cancer.
Should have a blood exam (20ml/each time) before the surgery and 3 months after the surgery.
In the case the disease recurs after the surgery, subjects need to receive the surgery again and take another blood exam before the surgery and 3 months after the surgery.
Before the surgery site staff must:
Collect subjects' saliva once a day (in the morning before breakfast) for 3 consecutive days.
Collect a 0.5x0.5Cm2 tissue sample of the tumor during the surgery.
- microRNA-29b [ Time Frame: 3 years ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02009852
|Contact: Shin-Jung Cheng, DDS, MS, PhD||+886 2 29251733 ext email@example.com|
|National Taiwan University Hospital research Ethics Committee||Recruiting|
|Taipei, Taiwan, 10048|
|Contact: Shin-Jung Cheng, 10048 +886 2 29251733 ext 67509 firstname.lastname@example.org|
|Principal Investigator: Shin-Jung Cheng, DDS, MS, PhD|
|Principal Investigator:||Shin-Jung Cheng, DDS, MS, PhD|